Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05892042 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction

Study acronym: ACTonLVT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 1, 2026 (before its estimated September 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Oct 1, 2024 to Sep 1, 2026
    • Study completion date: Apr 1, 2025 to Dec 1, 2026
    • Secondary endpoints: details revised at 1 of 7 entries
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Contemporary data are lacking regarding the management of left ventricular thrombus (LVT) developed after ST segment elevation myocardial infarction
Trial Details
NCT Number NCT05892042
Lead Sponsor Jilin University
Conditions
(from sponsor)		 ST-segment Elevation Myocardial Infarction (STEMI), Left Ventricular Thrombus
Related terms ST Elevation Myocardial Infarction
Enrollment 320 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov